Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseasesNathan A. Berger, Csaba Szabó, György Haskó et al.|British Journal of Pharmacology|2017Cited by 210
Gender- and age-dependencies of oxidative stress, as detected based on the steady state concentrations of different biomarkers in the MARK-AGE studyIlya Pinchuk, Dov Lichtenberg, Daniela Weber et al.|Redox Biology|2019Cited by 64
Associations of circulating GDF15 with combined cognitive frailty and depression in older adults of the MARK-AGE studyBastian Kochlik, Kristina Norman, Catrin Herpich et al.|GeroScience|2023Cited by 27
Medication Intake Is Associated with Lower Plasma Carotenoids and Higher Fat-Soluble Vitamins in the Cross-Sectional MARK-AGE Study in Older IndividualsDaniela Weber, Tilman Grune, Bastian Kochlik et al.|Journal of Clinical Medicine|2020Cited by 8
Association between redox biomarkers, DNA damage and aerobic capacity before and after physical stress in young menDaniela Weber, María Moreno‐Villanueva, Jonas Thimm et al.|Redox Biology|2025Cited by 5